Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The main objective of the trial is to demonstrate the efficacy of a two months pre-seasonal
treatment with AllerT 100 µg maintenance dose in reducing symptoms of allergic
rhinoconjunctivitis during the following birch pollen season